Join our community of smart investors

Microgen sets a tough pace

The provider of business-critical software saw huge sales growth and developed its two core divisions
July 26, 2017

A provider of business-critical software, Microgen (MCGN) has two main divisions: Aptitude Software, which streamlines financial reporting, and Microgen Financial Systems, which supports wealth managers. Aptitude was the greatest driver of Microgen’s huge top-line growth for the first half, achieving £19.5m in total sales, up 70 per cent, and increasing its recurring revenues by 42 per cent. The resultant 3 per cent share price decline was perhaps a reaction to management’s statement that the "exceptional growth in demand" seen for Aptitude will moderate in 2018. 

IC TIP: Hold at 420.5p

This revenue growth helped Aptitude lift its operating margin to 19 per cent from 15 per cent a year earlier, despite the firm’s continued investment in new products. Aptitude consolidated its position in the telecoms market and entered the US healthcare market with two new contracts.

Microgen saw a slight decline in its adjusted operating margin. This was attributed to an inevitable change in strategic direction, shifting away from the relatively mature, high-margin application management business in favour of the trust and fund administration market.

Analysts at Investec forecast adjusted pre-tax profits of £13.1m for the full year to December 2017, giving EPS of 15.2p (from £9.2m and 11.6p in 2016).

MICROGEN (MCGN)   
ORD PRICE:420.5pMARKET VALUE:£256m
TOUCH:418.0p-423.0p12-MONTH HIGH:439.5pLOW: 166.5p
DIVIDEND YIELD:1.3%PE RATIO:34
NET ASSET VALUE:75.7p*NET CASH:£6.9m
Half-year to 30 JuneTurnover (£m)Pre-tax profit (£m)Earnings per share (p)Dividend per share (p)
201619.53.85.11.50
201728.45.46.92.00
% change+45+43+35+33
Ex-div:3 Aug   
Payment:25 Aug   
*Includes intangible assets of £53m, or 87.0p a share